$ cat ./records/gates-foundation-commits-363-million-at-london-declaration-on-neg-2012.txt
Gates Foundation Commits $363 Million at London Declaration on Neglected Tropical Diseases to Eliminate 10 NTDs by 2020
[RECORD.TXT] · cat --full
On January 30, 2012, the Gates Foundation announced a five-year $363 million commitment as the lead funder of the London Declaration on Neglected Tropical Diseases, signed alongside WHO, 13 pharmaceutical companies, DFID, USAID, and the World Bank. The pledge targeted control or elimination of Guinea worm, lymphatic filariasis, river blindness, trachoma, and schistosomiasis. By 2020, trachoma was eliminated as a public health problem in 10 countries and preventive treatment coverage had more than doubled across all five diseases.
Free forever · No ads · Solo developer
If this was worth a read, help make the next entry possible.
Every entry in this archive was researched, verified, and written by one person — for free. No corporate funding. No ad revenue. Just a developer who believes verified history should be accessible to everyone. Your donation directly funds new entries.
Crypto accepted · No subscription required
← Previous
Gates Travels to Norway with Epstein and Meets Scientists in Oslo
Next →
Gates Foundation Awards $46 Million to Marie Stopes International for Reproductive Health
[CROSS_REFERENCES] · grep --category='Global Health'
Related Accomplishments
January 2026
Gates-backed World Mosquito Program reaches 16 million people protected from dengue via Wolbachia method
The World Mosquito Program — backed in part by the Gates Foundation — announced in January 2026 that its Wolbachia-infected mosquito releases had reached over 16.1 million people across multiple countries, including Colombia, Indonesia, Brazil, Sri Lanka, Fiji, Vanuatu, and Vietnam. Wolbachia-carrying Aedes aegypti mosquitoes — which block dengue, Zika, chikungunya, and yellow fever transmission — had established self-sustaining populations in treated cities without requiring ongoing releases. Gold-standard randomised trials in Indonesia showed a 77% reduction in dengue incidence. The program represented one of the largest and most cost-effective vector control deployments in history.
2025
Gates-Funded Monoclonal Antibody Shows Early Promise as a Single-Shot Malaria Shield
[ARCHIVE_FUNDING] · INDEPENDENT · NO ADS
One developer. >300 verified entries. Zero ads. Forever free.
No sponsors, no paywall, no algorithm. If this archive has been useful to you, reader support is what keeps it running.